Showing results (241-250 of 260) with videos related to

Sort By:
Pageof 26
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2016
Minibrain and Wings apart control organ growth and tissue patterning through down-regulation of CapicuaLiu Yang, Sayantanee Paul, Kenneth G Trieu, et al.
Pneumologie (Stuttgart, Germany)|January 15, 2021
[S2k Guideline - Recommendations for Inpatient Therapy of Patients with COVID-19]S Kluge, U Janssens, T Welte, et al.
Expert Review of Respiratory Medicine|October 29, 2013
Personalizing and targeting therapy for COPD: the role of molecular and clinical biomarkersFelicia Goh, Janet G Shaw, Santiyagu M Savarimuthu Francis, et al.
Genes and Immunity|May 23, 2003
Mannose-binding lectin gene polymorphism predicts hospital admissions for COPD infectionsI A Yang, S L Seeney, J M Wolter, et al.
Pneumologie (Stuttgart, Germany)|March 17, 2021
[Guideline for the Diagnosis and Treatment of Asthma - Addendum 2020 - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology]R Buhl, R Bals, X Baur, et al.
The European Respiratory Journal|February 2, 2008
Outcomes for COPD pharmacological trials: from lung function to biomarkersM Cazzola, W MacNee, F J Martinez, et al.
Nature Communications|October 29, 2025
scRNA-seq reveals persistent aberrant differentiation of nasal epithelium driven by TNFα and TGFβ in post-COVID syndromeK D Reddy, Y Maluje, F Ott, et al.
Pneumologie (Stuttgart, Germany)|December 8, 2017
[Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology], , , et al.
The Journal of Prevention of Alzheimer'S Disease|March 22, 2023
Investigating Partially Discordant Results in Phase 3 Studies of AducanumabC Mallinckrodt, Y Tian, P S Aisen, et al.
The Journal of Prevention of Alzheimer'S Disease|May 11, 2022
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's DiseaseS Budd Haeberlein, P S Aisen, F Barkhof, et al.
Pageof 26